References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
- Butler MS, Robertson AA, Cooper MA. 2014. Natural product and natural product derived drugs in clinical trials. Nat Prod Rep. 31(11):1612–1661.
- Ning D, Jin M, Xv T, Sun J, Li M. 2018. Homoisoflavanone-1 isolated from Polygonatum odoratum arrests the cell cycle and induces apoptosis in A549 cells. Oncol Lett. 16(3):3545–3554.
- K R, Maiti S, V S, Shin W-H, Kihara D. 2019. Implementation of pharmacophore-based 3D QSAR model and scaffold analysis in order to excavate pristine ALK inhibitors. Med Chem Res. 28(10):1726–1739.
- Zuo Y, Pu J, Chen G, Shen W, Wang B. 2019. Study on the activity and mechanism of skimmianine against human non-small cell lung cancer. Nat Prod Res. 33(5):759–762.
- Jung CH, Han AR, Chung HJ, Ha IH, Um HD. 2019. Linarin inhibits radiation-induced cancer invasion by downregulating MMP-9 expression via the suppression of NF-κB activation in human non-small-cell lung cancer A549. Nat Prod Res. 33(24):3582–3586.
- Songsiang U, Wanich S, Pitchuanchom S, Netsopa S, Uanporn K, Yenjai C. 2009. Bioactive constituents from the stems of Dalbergia parviflora. Fitoterapia. 80(7):427–431.
- Tian W, Han X, Yan M, Xu Y, Duggineni S, Lin N, Luo G, Li YM, Han X, Huang Z, et al. 2012. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. Biochemistry. 51(2):724–731.
- Yan M, Li G, An J. 2017. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions. Exp Biol Med (Maywood)). 242(11):1185–1197.
- Zhang X, Perez-Sanchez H, C Lightstone F. 2017. A comprehensive docking and MM/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem. 17(14):1631–1639. [InsertedFromOnline[pubmedMismatch]]